5-Y update of the randomized phase III trial DAHANCA19: Primary (Chemo) RT +/- zalutumumab in HNSCC

J. G. Eriksen, C. Maare, J. Johansen, H Primdahl, J. Evensen, C A Kristensen, Lisbeth Juhler Andersen, J Overgaard

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftpeer review

OriginalsprogEngelsk
ArtikelnummerOC-0271
TidsskriftRadiotherapy & Oncology
Vol/bind127
Udgave nummerSupplement 1
Sider (fra-til)S137-S138
Antal sider2
ISSN0167-8140
DOI
StatusUdgivet - 2018
Begivenhed37th Meeting of the European-Society-for-Radiotherapy-and-Oncology - Barcelona, Spanien
Varighed: 20 apr. 201824 apr. 2018

Konference

Konference37th Meeting of the European-Society-for-Radiotherapy-and-Oncology
LandSpanien
ByBarcelona
Periode20/04/201824/04/2018

Citationsformater